References
- Hussein MR, Sayed RH, Abu-Dief EE. Immune cell profile in invasive cholesteatomas: preliminary findings. Exp Mol Pathol 2010;88:316–23.
- Olszewska E, Wagner M, Bernal-Sprekelsen M, Ebmeyer J, Dazert S, Hildmann H, et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol 2004;261:6–24.
- Laws PM, Young HS. Current and emerging systemic treatment strategies for psoriasis. Drugs 2012;72:1867–80.
- Sarra M, Caruso R, Cupi ML, Monteleone I, Stolfi C, Campione E, et al. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-gamma-dependent epidermal hyperplasia. J Immunol 2011;186:5435–42.
- Monteleone G, Pallone F, Macdonald TT. Interleukin-21 as a new therapeutic target for immune-mediated diseases. Trends Pharmacol Sci 2009;30:441–7.
- Caruso R, Botti E, Sarra M, Esposito M, Stolfi C, Diluvio L, et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med 2009;15:1013–15.
- Chung JW, Yoon TH. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium. Acta Otolaryngol 1998;118:386–91.
- Kim CS, Lee CH, Chung JW, Kim CD. Interleukin-1 alpha, interleukin-1 beta and interleukin-8 gene expression in human aural cholesteatomas. Acta Otolaryngol 1996;116:302–6.
- Hilton CW, Ondrey FG, Wuertz BR, Levine SC. Interleukin-8 production in response to tumor necrosis factor-alpha by cholesteatoma keratinocytes in cell culture. Laryngoscope 2011;121:372–4.
- Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol 2003;111:S460–75.
- Akimoto R, Pawankar R, Yagi T, Baba S. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 2000;62:257–65.
- Bujia J, Kim C, Ostos P, Kastenbauer E, Hultner L. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol 1996;253:152–7.
- Helgaland T, Engelen B, Olsnes C, Aarstad HJ, Vassbotn FS. In vitro cholesteatoma growth and secretion of cytokines. Acta Otolaryngol 2010;130:815–19.
- Kato A, Ohashi Y, Masamoto T, Sakamoto H, Uekawa M, Nakai Y. Interleukin-6 and tumour necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the eustachian tube. Acta Otolaryngol Suppl 1998;538:90–7.
- Marenda SA, Aufdemorte TB. Localization of cytokines in cholesteatoma tissue. Otolaryngol Head Neck Surg 1995;112:359–68.
- Kuczkowski J, Sakowicz-Burkiewicz M, Izycka-Swieszewska E. Expression of the receptor activator for nuclear factor-kappaB ligand and osteoprotegerin in chronic otitis media. Am J Otolaryngol 2010;31:404–9.
- Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, Baird A, et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 2000;21:793–8.
- Botti E, Spallone G, Caruso R, Monteleone G, Chimenti S, Costanzo A. Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. Curr Pharm Biotechnol 2012;13:1861–7.